“The Impact of CYP2C9 and VKORC1 Polymorphism in Patient’s Response to Warfarin and Acenocoumarol” (2019) Journal of Medical Biomedical and Applied Sciences, 7(7), p. 260–266. doi:10.15520/jmbas.v7i7.193.